logo
Select company
Select metric
-387.14%Operating Cash Flow Margin
VS
Market
7
Sector
25
Industry
46
History
86
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information

Ticker

SNDX

Company Name

SYNDAX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SYNDAX PHARMACEUTICALS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNDX - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -302.67M-387.14%$ 78.18M
3/31/2025$ -286.52M-655.32%$ 43.72M
12/31/2024$ -274.9M-1160.91%$ 23.68M
9/30/2024$ -258.86M-1617.9%$ 16M
6/30/2024$ -241.19M-6891.29%$ 3.5M
3/31/2024$ -204.92M0%$ 0
12/31/2023$ -160.6M0%$ 0
9/30/2023$ -142.15M0%$ 0
6/30/2023$ -126.04M0%$ 0
3/31/2023$ -130.97M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) OCF % stands at -4508.97%.
  • Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average OCF % has been -2214.52%.
  • The median OCF % for SYNDAX PHARMACEUTICALS INC during this period was -908.11%
  • SYNDAX PHARMACEUTICALS INC reached its highest OCF % over the past 5 years at 20.85%.
  • The lowest OCF % recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe -6891.29%

SYNDAX PHARMACEUTICALS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
NRIX : NURIX THERAPEUTICS INC -275.29%URGN : UROGEN PHARMA LTD -130.66%TBPH : THERAVANCE BIOPHARMA INC 317.36%ZVRA : ZEVRA THERAPEUTICS INC -74.51%KURA : KURA ONCOLOGY INC 150.08%SAGE : SAGE THERAPEUTICS INC -410.94%GYRE : GYRE THERAPEUTICS INC 0.91%NKTR : NEKTAR THERAPEUTICS -246.76%EYPT : EYEPOINT PHARMACEUTICALS INC -367.23%ZYME : ZYMEWORKS INC -31.51%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for SYNDAX PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -68.36M ] / Revenues [ $ 1.52M ]
(=) OCF % [ -4508.97% ]

SNDX - Operating Cash Flow Margin, Last 5 years

-6891.29%

Minimum

Jun 30, 2024

20.85%

Maximum

Dec 31, 2021

-2214.52%

Average

-908.11%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%